23andMe gets FDA green light for cancer risk test

Show all

23andMe gets FDA green light for cancer risk test

 Genetic testing powerhouse 23andMe announced today that it’s officially received the FDA go-ahead to launch a direct-to-consumer testing kit for genes linked to various forms of cancer. The forthcoming kit, which will be made available without a prescription, tests for BRCA1 and BRCA2, which are linked to higher risk of ovarian, break and prostate cancer. “Being the first and… Read More

Powered by WPeMatico

Comments are closed.